The Food and Drug Administration (FDA) on Friday issued a warning about unauthorized fraudulent test kits intended for home use for COVID-19, the disease caused by CCP (Chinese Communist Party) virus, commonly known as the novel coronavirus.
“The agency is beginning to see unauthorized fraudulent test kits that are being marketed to test for COVID-19 in the home,” the FDA
announced. “We want to alert the American public that, at this time, the FDA has not authorized any test that is available to purchase for testing yourself at home for COVID-19.”
The FDA warned that results from the kits could “keep some patients from seeking care or delay necessary medical treatment,” and reminded consumers to follow the Centers for Disease Control and Prevention’s
guidelines and speak to their doctor if they have symptoms of COVID-19.
The agency said that it is increasing checks at ports of entry, including International Mail Facilities, to help prevent fraudulent products coming to the United States. People who know of fake test kits for COVID-19 should also report to the agency, it said.
“We will continue to aggressively pursue those who place the public health at risk and hold bad actors accountable,” the FDA said, adding that this may include issuing warning letters, seizures or injunctions.
Earlier, the FDA
issued warning letters to seven companies that were found to have been selling products claiming to treat or prevent COVID-19.
Trump on Thursday declared that the
Chinese communist regime is to blame for the CCP virus, which has spread to more than 160 countries and territories around the world, killing thousands.
Human-to-human transmission of COVID-19 was occurring from at least mid-December 2019 in Wuhan, according to a paper published in the New England Journal of Medicine on Jan. 29. The
paper found that “there is evidence that human-to-human transmission has occurred among close contacts since the middle of December 2019.”
Chinese authorities did not confirm human-to-human transmission until Jan. 20—almost three weeks after the disease was first officially reported on Dec. 31, 2019. The first patient reported with the virus exhibited symptoms on Dec. 1.
Cathy He contributed to this report.